189 related articles for article (PubMed ID: 35831680)
21. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
Bellucci S; Michiels JJ
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
[TBL] [Abstract][Full Text] [Related]
22. A new JAK2 gene mutation in patients with polycythemia vera and splanchnic vein thrombosis.
Colaizzo D; Amitrano L; Tiscia GL; Grandone E; Guardascione MA; Margaglione M
Blood; 2007 Oct; 110(7):2768-9. PubMed ID: 17881638
[No Abstract] [Full Text] [Related]
23. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
Gumina RJ; Foley DA; Tefferi A; Rooke TW; Shields RC
Angiology; 2002; 53(5):587-91. PubMed ID: 12365868
[TBL] [Abstract][Full Text] [Related]
24. The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera.
Pieri L; Bogani C; Guglielmelli P; Zingariello M; Rana RA; Bartalucci N; Bosi A; Vannucchi AM
Haematologica; 2009 Nov; 94(11):1537-45. PubMed ID: 19608683
[TBL] [Abstract][Full Text] [Related]
25. Direct intrahepatic portocaval shunt for treatment of portal thrombosis and Budd-Chiari syndrome.
Pedersen MR; Molloy P; Wood D; Seetharam A
Ann Hepatol; 2016; 15(1):127-30. PubMed ID: 26626649
[TBL] [Abstract][Full Text] [Related]
26. A Balanced Robertsonian Translocation in a Patient with a Janus Kinase 2-Positive Polycythemia Vera.
Strasser B; Paar C; Kiesl D; Tomasits J
Lab Med; 2022 Sep; 53(5):e101-e104. PubMed ID: 34940837
[TBL] [Abstract][Full Text] [Related]
27. Polycythemia vera and the Jak2(V617F) mutation in a case of hereditary spherocytosis.
Fleischman RA
Am J Med Sci; 2013 Oct; 346(4):328-30. PubMed ID: 23588264
[TBL] [Abstract][Full Text] [Related]
28. [A case of cavernoma of portal vein associated with polycythemia vera].
Kim KT; Lee SW; Han SY; Kim BH; Kang KT; Roh MH; Han JY
Korean J Hepatol; 2006 Dec; 12(4):568-73. PubMed ID: 17237636
[TBL] [Abstract][Full Text] [Related]
29. Familial polycythemia vera with Budd-Chiari syndrome in childhood.
Cario H; Pahl HL; Schwarz K; Galm C; Hoffmann M; Burdelski M; Kohne E; Debatin KM
Br J Haematol; 2003 Oct; 123(2):346-52. PubMed ID: 14531919
[TBL] [Abstract][Full Text] [Related]
30. Is there a gender effect in polycythemia vera?
Palandri F; Mora B; Gangat N; Catani L
Ann Hematol; 2021 Jan; 100(1):11-25. PubMed ID: 33006021
[TBL] [Abstract][Full Text] [Related]
31. Extent of hematopoietic involvement by TET2 mutations in JAK2V⁶¹⁷F polycythemia vera.
Swierczek SI; Yoon D; Bellanné-Chantelot C; Kim SJ; Saint-Martin C; Delhommeau F; Najman A; Prchal JT
Haematologica; 2011 May; 96(5):775-8. PubMed ID: 21273266
[TBL] [Abstract][Full Text] [Related]
32. JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis.
Martínez-Avilés L; Besses C; Alvarez-Larrán A; Cervantes F; Hernández-Boluda JC; Bellosillo B
Haematologica; 2007 Dec; 92(12):1717-8. PubMed ID: 18056003
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of microRNA in polycythemia vera.
Bruchova H; Merkerova M; Prchal JT
Haematologica; 2008 Jul; 93(7):1009-16. PubMed ID: 18508790
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric Derangement by Polycythemia Vera: A Case Report of an Unexpected Disease Presentation and Review of the Literature.
De Lil H; van Beek M; Herbers A; van der Holst E; Keijsers K
Acta Haematol; 2021; 144(6):706-711. PubMed ID: 34247161
[TBL] [Abstract][Full Text] [Related]
35. JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type I.
Berman JN; Greer WL; Archambeault S; Loh ML; Riddell C; Morash B; Dumas N; Fernandez CV; Ludman MD
Pediatr Blood Cancer; 2008 Nov; 51(5):689-91. PubMed ID: 18623221
[TBL] [Abstract][Full Text] [Related]
36. The development of gastric cancer in a patient with polycythemia Vera, 3P deletion, and JAK2 V617F mutation.
Ayvaz O; Yavasoglu I; Kadikoylu G; Meydan N; Barutca S; Bolaman Z
J Gastrointest Cancer; 2010 Dec; 41(4):254-6. PubMed ID: 20306156
[TBL] [Abstract][Full Text] [Related]
37. The V617F mutation of JAK2 is very uncommon in patients with thrombosis.
Remacha AF; Estivill C; Sarda MP; Mateo J; Souto JC; Canals C; Nomdedéu J; Fontcuberta J
Haematologica; 2007 Feb; 92(2):285-6. PubMed ID: 17296594
[TBL] [Abstract][Full Text] [Related]
38. [CME: Polycythemia vera].
Wellauer Atencio M; Goede JS
Praxis (Bern 1994); 2019 Sep; 108(13):835-842. PubMed ID: 31571535
[TBL] [Abstract][Full Text] [Related]
39. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.
Cornea MI; Levrat E; Pugin P; Betticher DC
J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587
[TBL] [Abstract][Full Text] [Related]
40. Masked polycythaemia vera in a patient with extrahepatic portal venous obstruction.
Pati HP; Dayal S; Kashyap R; Padhy AK
Eur J Gastroenterol Hepatol; 1998 Oct; 10(10):883-5. PubMed ID: 9831412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
